Have You or a Loved One Suffered Complications From An Impella Heart Pump?

The primary catalyst behind the extensive litigation involves the mechanical shape and deployment behavior of left-sided catheters (encompassing models including the Impella 2.5, Impella CP, Impella CP with SmartAssist, Impella 5.0, Impella 5.5, and Impella LD). These miniaturized pumps are threaded through the femoral artery directly into the left ventricle—the heart’s primary pumping chamber. Once positioned, the Impella heart pump pulls blood from the ventricle and pushes it into the aorta to maintain systemic blood pressure.

The underlying hazard stems from a profound design vulnerability of the Impella heart pump. The catheter tubing behaves rigidly inside active, contracting heart chambers. During standard operation, the tip of the catheter can press aggressively against the ventricular muscle tissue. Rather than gliding safely, the device can cut through the wall of the left ventricle like a surgical instrument. According to official safety warnings issued by the U.S. Food and Drug Administration (FDA), this mechanical pressure causes an instantaneous left ventricular perforation or free wall rupture, leading to severe internal hemorrhaging (bleeding), critical hypotension (blood pressure falling out), and an immediate risk of death.

In addition to the physical catheter risks, regulatory filings detail a history of critical failures involving the Automated Impella Controller (AIC)—the primary console that regulates the heart pump’s motor speed and purge fluid pressures. The FDA designated the safety corrections for these devices as Class I Recalls—the agency’s most urgent enforcement classification—detailing a laundry list of technical defects.

These system issues include:

• Internal Software Reboot Errors: An intrinsic software flaw could cause controllers to spontaneously trigger a forced hard restart if a patient experienced low pulsatility for more than 80 minutes, leaving vulnerable heart patients without life-sustaining hemodynamic support during a system reboot.
• Electrical & Structural Failures: The heart pump was prone to electrostatic discharge that could instantly interrupt motor controls or dislodge memory cards. Faulty on-board capacitors could also cause the pump and purge mechanism to stop. Regulatory tracking on the official FDA Early Alert Portal continues to highlight quality issues with AIC consoles that delay critical life-sustaining therapy.

Allegedly, corporate bulletins outlining the heart-wall puncture risks associated with the Impella heart pump were quietly circulated internally as early as 2021. However, the manufacturer allegedly failed to update the instructions for use that accompany every Impella heart pump, or notify federal oversight bodies for years. This failure to warn led directly to an official FDA warning letter penalizing the company for concealing known patterns of severe injury and death associated with the heart pump.

When an implantable heart pump fails or tears through cardiac tissue, the injuries are typically catastrophic. An internal ventricular tear can result in massive sudden blood loss, leaving families facing unexpected losses. The medical device litigation team at TheLawFirm.com is actively reviewing heart pump cases to ensure negligent manufacturers are held accountable.

You do not need to possess your complete operating room records or know the specific serial number of the heart pump console utilized during the emergency to initiate an assessment. If your family member suffered a ventricular rupture, massive internal bleeding, or sudden pump failure while on an Impella left-sided heart pump, our team will manage the process of ordering and reviewing your medical charts. We represent clients strictly on a contingency fee contract—guaranteeing that you pay nothing out of pocket unless we successfully secure a recovery for your family.

Visit our centralized Lawsuit List to check additional product liability and pharmaceutical statuses.